Innovative cancer therapies emerge due to significant number of Lymphoma R&D projects

Decision-making requires a vast amount of structured information. Although paramount to establishing a representative description of a particular field, identifying and structuring information is a tedious task. When generating an information structure, it is essential to make it as complete as possible in order to analyze and draw correct conclusions from the field.

(PRWEB) December 25, 2003 --Research and Markets announces the addition of the "Lymphoma R&D Database"

Decision-making requires a vast amount of structured information. Although paramount to establishing a representative description of a particular field, identifying and structuring information is a tedious task. When generating an information structure, it is essential to make it as complete as possible in order to analyze and draw correct conclusions from the field. For your convenience, we have identified and structured more than 220 industry related lymphoma R&D projects, compiled in the first edition of this database. This collection of data describes the R&D activities in this field as near completely as possible.

Compiling the information in a database file for convenient transfer of data to your preferred information system will save hundreds of working hours for you. Depending on the aim of your analysis, it will enable you to produce simple as well as advanced information analysis on the spot. Use the database to produce key tables and automated graphs in no more than a few minutes!

This is one of the world's most comprehensive and updated information sources describing the structure of the lymphoma R&D situation. It includes information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapies, antigen- or cellular-based vaccines, liposomal and antiangiogenesis drugs.

This database includes information from More than 220 industry related lymphoma R&D projects,
Information on more than 110 companies active in lymphoma R&D, Data from 139 clinical trials and Information on over 40 preclinical projects

For a complete index of this report click on http://www.researchandmarkets.com/reports/41838

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
###